Position in GNLX
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$30,842
-$24,726 QoQ
Shares Held
12,745
0.0% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GNLX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Stratos Wealth Partners, LTD. holds $11,734,127 across 20 Biotechnology names. GNLX ranks #17 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZVRA |
Zevra Therapeutics, Inc.
|
408,000 | $3,802,560 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,299 | $1,473,135 | |
| 3 | PHAT |
Phathom Pharmaceuticals, Inc.
|
100,000 | $1,111,000 | |
| 4 | PLX |
Protalix BioTherapeutics, Inc.
|
500,000 | $1,085,000 | |
| 5 | INCY |
Incyte Corp
|
6,895 | $648,957 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
7,715 | $579,319 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
6,640 | $493,086 | |
| 8 | EXEL |
Exelixis, Inc.
|
9,093 | $389,998 |
All Filings in GNLX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $30,842 | 12,745 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $55,568 | 12,745 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $53,529 | 12,745 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $36,578 | 12,745 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $34,411 | 12,745 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $52,498 | 22,245 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $53,386 | 22,526 | Shares | Sole | 2024-10-17 | |
| No filing history on record for this holder in this stock. | ||||||